This is a delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to The Regents of the University of California, San Francisco (UCSF) for the NCI SEER Patterns of Care (POC)/Quality of Care Study for diagnosis year 2019, focusing on urinary bladder cancer and kidney cancer. The $178,096 firm fixed price contract is part of the Surveillance Epidemiology and End Results (SEER) program master indefinite...
This is a delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to the Department of Public Health Connecticut, a state government entity. The contract supports the NCI Patterns of Care (POC)/Quality of Care Study, specifically for diagnosis year 2019 relating to urinary bladder cancer and kidney cancer. The $78,144.00 firm-fixed price contract has an ultimate completion date of April 4, 2022. The contract is a delivery order under the larger Surveillance...
This is a delivery order contract awarded to the University of Kentucky Research Foundation (the Research Foundation) by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). The $211,456 firm fixed-price award is for the NCI's Surveillance, Epidemiology, and End Results (SEER) Patterns of Care (POC)/Quality of Care Study for diagnosis year 2019, focused on urinary bladder cancer and kidney cancer. The contract has an ultimate completion date of April 4, 2022...
This is a $343,502 firm fixed price delivery order contract awarded to the Public Health Institute (PHI), a non-profit organization, by the National Cancer Institute (NCI). The contract is part of the NCI's Patterns of Care (POC)/Quality of Care Study focused on urinary bladder cancer and kidney cancer diagnosed in 2019. The contract does not have a set-aside designation. PHI has a long track record of managing federal contracts and grants, including prior work with the NCI, Centers for...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $58,477 firm fixed price delivery order contract to the Idaho Hospital Association Inc., a non-profit organization, to conduct a Patterns of Care (POC)/Quality of Care Study on non-small cell lung cancer (NSCLC) patients diagnosed in 2017 and NSCLC and melanoma patients diagnosed in 2018. This contract is part of the NCI Patterns of Care (POC)/Quality of Care Study program and will...
This contract was awarded by the National Institutes of Health (NIH) National Cancer Institute to the Cancer Prevention Institute of California, a non-profit organization, to conduct a "Patterns of Care/Quality of Care Study: Diagnosis Year 2016" from July 31, 2017 to July 30, 2018. The contract, which has a firm fixed price of $159,811.00, is a delivery order that is not set aside for any particular business type. The study is part of the Surveillance, Epidemiology and End Results...
The National Cancer Institute (NCI) awarded a $80,709 fixed-price delivery order contract to Louisiana State University Health Sciences Center New Orleans (LSU Health Sciences Center New Orleans) to conduct a Patterns of Care/Quality of Care Study on urinary bladder cancer and kidney cancer diagnosed in 2019. This contract is part of the NCI's larger Surveillance, Epidemiology, and End Results (SEER) program. The contract does not have a set-aside designation, indicating it was competed on a...
This is a $72,901 firm-fixed price purchase order contract awarded by the National Cancer Institute (NCI) to the University of Utah Office of Sponsored Projects Division. The contract is for the NCI Patterns of Care Study to abstract medical records for prostate cancer, ovarian cancer, and small intestine cancer diagnosed in 2021. The study aims to describe the use of recommended biomarker tests and targeted therapies, compare treatment patterns over time and across demographics, and document...
This contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to the Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance), a non-profit medical research organization. The contract, valued at $109,264.00, is for the National Cancer Institute's Patterns of Care Study to collect data on diagnosis year 2020 breast and colorectal cancer cases, including the use of biomarker tests, targeted therapies, adjuvant...
The National Cancer Institute awarded a purchase order to Dana-Farber Cancer Institute, Inc. for germline DNA samples and data from renal cell carcinoma patients supporting the National Cancer Institute's Renal Cell Carcinoma Genome-Wide Association Study, with a ceiling value of $18,000.00 and an award date of April 10, 2019. Work is performed in Boston, Massachusetts under firm fixed-price terms, with ultimate completion on April 9, 2020. The purchase order procures biological specimens and...